Ako Hosono

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report.

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report.

Journal: Frontiers in oncology

Published: April 14, 2026

East Asian multi-centre study on clinical long-term outcomes of postoperative proton beam therapy for localised paediatric intracranial ependymoma.

East Asian multi-centre study on clinical long-term outcomes of postoperative proton beam therapy for localised paediatric intracranial ependymoma.

Journal: Clinical and translational radiation oncology

Published: April 10, 2026

Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report.

Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report.

Journal: Frontiers in oncology

Published: February 01, 2026

Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma.

Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma.

Journal: The oncologist

Published: January 20, 2026

Impact of everolimus-related interstitial lung disease on subsequent treatment in patients with metastatic breast cancer.

Impact of everolimus-related interstitial lung disease on subsequent treatment in patients with metastatic breast cancer.

Journal: The oncologist

Published: December 06, 2025

Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study.

Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study.

Journal: Gynecologic oncology

Published: October 19, 2025

Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer.

Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: October 13, 2025

Exploring Health Care Needs and HR-QOL Among Women With Cancer: A Principal Component Analysis Before and 6 Months After Treatment Initiation.

Exploring Health Care Needs and HR-QOL Among Women With Cancer: A Principal Component Analysis Before and 6 Months After Treatment Initiation.

Journal: Journal of clinical nursing

Published: July 07, 2025

Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer.

Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: January 29, 2025

Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case Report.

Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case Report.

Journal: Case reports in oncology

Published: January 14, 2025

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer.

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer.

Journal: Cancer treatment and research communications

Published: January 04, 2025

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

Journal: Cancer medicine

Published: February 09, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026